Piramal Pharma Ltd.

NSE: PPLPHARMA | BSE: 543635 | ISIN: INE0DK501011 | Industry: Pharmaceuticals
| Expensive Performer
170.1400 -2.07 (-1.20%)
NSE Jan 01, 2026 13:49 PM
Volume: 1.2M
 

logo
Piramal Pharma Ltd.
04 Feb 2024
170.14
-1.20%
buy
by Edelweiss
Target: 150
Edelweiss
CDMO business to drive growth
 
Piramal Pharma Ltd. has an average target of 262.67 from 3 brokers.
More from Piramal Pharma Ltd.
Recommended
Will the smallcap investor run out of patience in 2026?
The Baseline | 01 Jan 2026, 11:23AM
Market closes higher amid strong buying in steel stocks
Trendlyne Marketwatch | 31 Dec 2025, 04:01PM
2025 turns selective on returns: Themes outperform while headline indices stall
The Baseline | 31 Dec 2025, 03:05PM